INTERLEUKIN-19 - Patent 0963377

(19)

(11)

EP 0 963 377 A1

(12)

(43)	Date of publication:
	15.12.1999 Bulletin 1999/50

(21)	Application number: 96932967.0

(22)	Date of filing: 30.08.1996

(51)

International Patent Classification (IPC):

C12N 15/ 09^{( . )}
A61K 39/ 395^{( . )}
C07K 14/ 52^{( . )}
C07K 16/ 24^{( . )}
C12N 1/ 19^{( . )}
C12N 5/ 10^{( . )}
C12P 21/ 02^{( . )}

A61K 38/ 00^{( . )}
A61P 37/ 02^{( . )}
C07K 14/ 54^{( . )}
C12N 1/ 15^{( . )}
C12N 1/ 21^{( . )}
C12N 15/ 19^{( . )}
C12P 21/ 08^{( . )}

(86)	International application number:
	PCT/US1996/014355

(87)	International publication number:
	WO 1998/008870 (05.03.1998 Gazette 1998/09)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(60)	Divisional application:
	08019123.2 / 2065396

(71)	Applicant: HUMAN GENOME SCIENCES, INC.
	Rockville, MD 20850-3338 (US)

(72)	Inventors:
	ROSEN, Craig, A. Laytonsville, MD 20882 (US) KENNY, Joseph, J. Rockville, MD 20851 (US)

(74)	Representative: VOSSIUS & PARTNER
	Siebertstrasse 4 81675 München 81675 München (DE)

(54)	INTERLEUKIN-19